Lumen Faces 2 Ransomware Attacks, Working With Experts To Evaluate And Minimize Impact

On March 27, 2023, Lumen Technologies, Inc (NYSE:LUMN) reported it faced two cybersecurity incidents. Last week Lumen discovered that a malicious intruder had…
  • On March 27, 2023, Lumen Technologies, Inc (NYSE:LUMN) reported it faced two cybersecurity incidents.
  • Last week Lumen discovered that a malicious intruder had inserted criminal ransomware into a limited number of its servers that support a segmented hosting service, degrading the operations of a small number of its enterprise customers. 
  • Lumen’s recent implementation of enhanced security software has led to its discovery that a separate sophisticated intruder accessed a limited number of its internal information technology systems. 
  • Also Read: Microsoft Cautions Against More Russia Led Ransomware Attack
  • Lumen does not believe the incidents will likely adversely impact its ability to serve its customers or its business, operations, or financial results per its investigation.
  • Lumen is working with outside forensic firms to contain the incidents and implementing business continuity plans to restore functionality to its customers’ operational and business systems. 
  • Lumen also notified law enforcement and regulatory authorities, impacted customers, launched investigations, and took additional steps to safeguard its systems. 
  • Lumen is working with several external advisors, impacted customers, and relevant authorities to assess and mitigate the impacts of the ransomware incidents. 
  • Price Action: LUMN shares traded higher by 2.90% at $2.48 on the last check Monday.
Total
0
Shares
Related Posts
Read More

CG Oncology Announces Data From The Phase 3 BOND-003 Study Evaluating The Efficacy And Safety Of Cretostimogene Monotherapy, Demonstrated 75.2% Complete Response Rate In High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

- Phase 3 BOND-003 study results showed sustained, durable complete responses over 12 months with novel investigational oncolytic immunotherapy - - Company will hold an investor conference call today at 4:30pm EDT

CGON

Read More

Passive Income Stream Or Yield Trap – Are High Dividend REITs Worth The Risk?

What if it was possible to make 10%, 20% or more in annual dividend income on a real estate investment trust (REIT) stock? Does the idea of a double-digit dividend yield conjure up images of a new sports car, yacht or mansion? Well, not so fast. REIT stocks with double-digit dividend yields are among the highest risks on the market.

ARR